Telmione Plus Tablet 40/12.5 mg

Adult dose

In patients whose blood pressure is not adequately controlled with Telmisartan alone, this medication should be taken once daily with or without food, along with a beverage. Though the dosage of each component is fixed, it is recommended to adjust the dosage of each component according to the individual before changing the administration. Patients with mild to moderate renal impairment do not require dosage adjustment, while this medication should not be administered to patients with severe renal impairment. Patients with mild to moderate hepatic impairment should use this medication with caution.

Child dose

Safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to patients who are allergic to the ingredients or excipients, pregnant or breastfeeding women, patients with severe liver or kidney disease, and those with certain electrolyte abnormalities. Elderly patients or those with high serum potassium levels, impaired liver function, or cardiovascular diseases should use this medication with caution. This medication can cause various adverse reactions, with common symptoms including dizziness, hypotension, diarrhea, and rash, while serious skin reactions or renal dysfunction may occur rarely. The component Telmisartan is primarily excreted by the liver; therefore, it is contraindicated in patients with severely impaired liver function, and this medication should not be used in patients with severely impaired kidney function. Patients with fluid or sodium deficiency may experience a rapid drop in blood pressure initially; hence caution is necessary. This medication can interact with other antihypertensives, lithium, potassium supplements, non-steroidal anti-inflammatory drugs, etc., so patients should consult a physician or pharmacist if they are taking any other medications. Women planning pregnancy are advised to switch to a safer antihypertensive treatment instead, and if pregnancy is confirmed, this medication should be discontinued immediately. Breastfeeding women are advised not to take this medication, as it can be secreted in breast milk and affect the baby. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, requiring immediate medical attention. This medication is not recommended for pediatric patients under 18 years of age, as its safety and efficacy have not been established. Drowsiness or dizziness may occur during treatment; thus, it is advisable to avoid driving or operating dangerous machinery. This medication can cause photosensitivity, so patients should take precautions against UV exposure while on this medication.

Serious side effects

Urticaria, angioedema (including fatal outcomes), severe swelling (edema), tightness in the chest, difficulty breathing, cold sweats, paleness, severe rash with fever, blistering, skin peeling, mucosal pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, loss of consciousness

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, visual disturbances, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, cough, pulmonary inflammation, pulmonary edema, diarrhea, dry mouth, bloating, abdominal pain, constipation, indigestion, vomiting, liver function abnormalities/hepatic impairment, erythema, pruritus, rash, hyperhidrosis, urticaria, back pain

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance

Oval-shaped tablet with a white/pink two-layer structure, where the white layer may have pink spots.

Package unit

30 tablets/box (10 tablets/Alu-Alu X 3)